Immediate Impact
34 standout
Citing Papers
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside
2024 Standout
Biologics, theranostics, and personalized medicine in drug delivery systems
2024 Standout
Works of Todd Lewis being referenced
A Critical Review of the Efficacy and Safety of Inclisiran
2021
<p>A spotlight on alirocumab in high cardiovascular risk patients with type 2 diabetes and mixed dyslipidemia: a review on the emerging data</p>
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Todd Lewis | 92 | 17 | 1 | 37 | 32 | 13 | 169 | |
| Moo‐Seok Park | 31 | 11 | 41 | 32 | 19 | 219 | ||
| M. Picó | 55 | 5 | 1 | 36 | 49 | 20 | 286 | |
| H A Weizel | 47 | 4 | 1 | 14 | 16 | 9 | 159 | |
| Carina Wasslavik | 55 | 13 | 28 | 31 | 14 | 295 | ||
| P. Di Emidio | 106 | 33 | 5 | 43 | 12 | 16 | 274 | |
| Brigitte Onraed | 68 | 4 | 95 | 14 | 17 | 260 | ||
| Dorota Lebiedz‐Odrobina | 33 | 8 | 9 | 36 | 10 | 153 | ||
| Naina L. Gross | 35 | 34 | 1 | 27 | 9 | 17 | 154 | |
| Fleur Cohen | 38 | 4 | 16 | 18 | 15 | 189 | ||
| MURRAY H. BASS | 24 | 4 | 14 | 39 | 12 | 181 |
All Works
Loading papers...